Results 61 to 70 of about 2,521 (195)

Post Hoc Analysis of a Previous Study of Estetrol 15 mg/Drospirenone 3 mg Combination for Dysmenorrhea and Uterine Bleeding in Adenomyosis Patients

Reproductive Medicine and Biology, Volume 25, Issue 1, January/December 2026.
ABSTRACT Purpose To clarify the efficacy and safety of the estetrol 15 mg/drospirenone 3 mg combination among Japanese women with adenomyosis by post hoc analyses of a previous randomized clinical study. Methods Post hoc analyses were performed using data from a 16‐week, multi‐center, randomized, double‐blinded, placebo‐controlled, parallel‐group study,
Tasuku Harada, Takao Kobayashi, Eri Koga, Masayoshi Nogami, Ayaka Sasahara, Toshiaki Takayanagi, Masashi Hirayama, Yutaka Osuga   +7 more
wiley   +1 more source

Efficacy of oral contraceptive pills versus dienogest on endometriosis pain scores: a prospective cohort study

Middle East Fertility Society Journal
Background Endometriosis is a chronic gynecological condition associated with pelvic pain, dysmenorrhea, dyspareunia, and impaired quality of life. Medical management aims to reduce symptoms and prevent recurrence. The primary objective of this study was
Mahmoud Abdallah, Asmaa S. Mohamed, Ahmed Soliman, Walid M. Tawfik   +3 more
doaj   +1 more source

Comparative assessment of effectiveness of new drugs for targeted therapy of endometriosis by experimental model [PDF]

Гинекология, 2018
Introduction. The chronic, progressive, recurrent nature of the endometriosis results new avenues of targeted therapy for genital endometriosis with high therapeutic efficacy and minimal side effects must be explored.
M I Yarmoliskaya, M A Petrosyan, M S Florova, A S Molotkov, A S Denisova, E V Suslova, S Sh Tkhazaplizheva   +6 more
doaj   +1 more source

Preoperative Hemostatic Management for Refractory Abnormal Uterine Bleeding in Patients With von Willebrand Disease: A Case Report

Case Reports in Obstetrics and Gynecology, Volume 2026, Issue 1, 2026.
Introduction von Willebrand disease (VWD) is the most frequent inherited bleeding disorder in women, characterized by quantitative or qualitative deficiency in von Willebrand factor (VWF). This deficiency in functional VWF has a dual effect on hemostasis, resulting in impaired coagulation; thus, it may cause unstoppable abnormal uterine bleeding (AUB).
Rabbania Hiksas, Lisa Novianti, Intan Indah Permatasari, Thalia Amila Elsiyana, Aisyah Retno Puspawardani, Achmad Kemal Harzif, Harleen Khatra   +6 more
wiley   +1 more source

Long-term follow-up of the effect of oral dienogest and dienogest/ethinylestradiol treatment on cell-free DNA levels in patients with deep endometriosis. [PDF]

Eur J Med Res
Background Endometriosis is currently considered a systemic inflammatory disease and different non-invasive inflammatory markers, such as cell-free DNA (cfDNA), have recently been evaluated.
Torres PC, Tàssies D, Castillo H, Gracia M, Feixas G, Reverter JC, Carmona F, Martínez-Zamora MA.   +7 more
europepmc   +2 more sources

Combined Management of a Rare Case of an Incarcerated Intrauterine Device: Case Report and Review of the Literature

Case Reports in Obstetrics and Gynecology, Volume 2026, Issue 1, 2026.
Background Hormonal intrauterine systems are widely used for long‐acting reversible contraception and for managing gynecological conditions such as heavy menstrual bleeding and endometrial hyperplasia. Although rare, complications such as uterine embedment and perforation can occur, potentially leading to device malfunction or injury displacement. This
Stefano Restaino, Federico Paparcura, Elisa Rizzante, Silvia Zermano, Annalisa Graziano, Antonio Ferraro, Margherita Cuman, Alice Poli, Martina Arcieri, Lorenza Driul, Giuseppe Vizzielli, Gabriel Levin   +11 more
wiley   +1 more source

Non-inferiority study to compare the efficacy of relugolix with dienogest for endometriosis-associated pain and usefulness of administering relugolix prior to dienogest (READY study): study protocol for a multicenter randomized controlled study

Trials
Background Endometriosis presents as endometrial tissue growths outside the uterine cavity with its major symptoms including dysmenorrhea and infertility.
Fuminori Taniguchi, Motoko Fukui, Yutaka Osuga, Tasuku Harada, Jo Kitawaki   +4 more
doaj   +1 more source

Safety and Tolerability of Three Different Prolonged‐Release Dienogest/Ethinylestradiol Contraceptive Pills in an Extended 181‐Day Treatment Regimen Compared to a Flexible Immediate‐Release Formulation With Drospirenone/Ethinylestradiol

International Journal of Clinical Practice, Volume 2026, Issue 1, 2026.
Objective This trial was conducted to investigate the bleeding pattern, tolerability, and safety of the low‐dose prolonged‐release combined oral contraceptive (COC) containing dienogest (DNG) and ethinylestradiol (EE) in three different dosages for an extended regimen.
Pedro-Antonio Regidor, Alicyoy Angulo, Alejandro Munoz, Enrico Colli, Bing Niu   +4 more
wiley   +1 more source

Letrozole versus dienogest in endometrioma recurrent after surgery: a randomized controlled trial

, 2022
Background: Letrozole is a third-generation aromatase inhibitor. As there is aberrant aromatase production by endometriotic stromal cells and the growth and regression of endometriosis is estrogen-dependent, the use of letrozole to reduce the size and ...
Halder, Suravi, Amir, Mumtahena, Ishrat, Shakeela, Hossain, M. Rifat Zia, Nasrin, Ivy, Rahman, Farzana   +5 more
core   +1 more source

Effect of the progestin dienogest for treatment of endometriosis-associated pelvic pain

, 2022
Bakgrund: Endometrios är en sjukdom beroende av östrogen där endometriotisk vävnad tillväxer utanför livmodern, i exempelvis bäcken eller äggstockarna. Symtomen är bäckensmärta, dysmenorré och djup dyspareuni som kommer under skov. Infertilitet kan också
Behrouz, Bahar
core   +1 more source